UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Foundations Investment Advisors LLC

Key Points

• Foundations Investment Advisors LLC reduced its stake in UnitedHealth Group by 3.3% during the first quarter, now holding 54,391 shares worth approximately $28.5 million.
• Several institutional investors significantly increased their positions in UnitedHealth Group, with GAMMA Investing LLC raising its stake by over 56,000%, now owning over 8.2 million shares valued at $4.34 billion.
• UnitedHealth Group recently increased its quarterly dividend to $2.21 per share, representing an annualized yield of 3.15% and a payout ratio of 37.02%.

Foundations Investment Advisors LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 54,391 shares of the healthcare conglomerate's stock after selling 1,874 shares during the quarter. Foundations Investment Advisors LLC's holdings in UnitedHealth Group were worth $28,487,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Financial Management Professionals Inc. boosted its holdings in UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares during the period. Global Wealth Strategies & Associates boosted its holdings in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after acquiring an additional 20 shares during the period. Kolinsky Wealth Management LLC boosted its stake in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after buying an additional 21 shares during the period. Retirement Planning Group LLC boosted its stake in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after buying an additional 21 shares during the period. Finally, Net Worth Advisory Group boosted its stake in shares of UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of several recent research reports. Oppenheimer decreased their price objective on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research note on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price objective for the company. in a research note on Wednesday, June 11th. KeyCorp cut their target price on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. Piper Sandler cut their target price on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research report on Tuesday, June 3rd. Finally, TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $392.29.

UnitedHealth Group Price Performance

Shares of UNH traded up $1.07 during trading hours on Monday, reaching $282.13. 15,660,453 shares of the company traded hands, compared to its average volume of 12,409,642. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $255.93 billion, a PE ratio of 11.81, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The stock has a fifty day simple moving average of $300.91 and a 200 day simple moving average of $422.56.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 3.13%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director directly owned 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.